COUNTERPOINT: Should Asymptomatic OSA Be Treated in Patients With Significant Cardiovascular Disease? No

Overview of attention for article published in CHEST, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog

twitter: 6 X users

Readers on

mendeley: 15 Mendeley

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 83,009 followers.

COUNTERPOINT: Should Asymptomatic OSA Be Treated in Patients With Significant Cardiovascular Disease? No https://t.co/0BaGXsng12

Point/Counterpoint: Should asymptomatic OSA be treated in patients with significant cardiovascular disease? Read the debate from the March issue. Point: https://t.co/uzTkIcLxA1 Counterpoint: https://t.co/yFsTfAHEeh https://t.co/uctF13z7Lh

RT @accpchest: Point/Counterpoint: Should asymptomatic OSA be treated in patients with significant cardiovascular disease? Read the debat…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.